Various studies have been conducted on factors affecting colorectal cancer in elderly patients, including the use of adjuvant chemotherapy, detection and staging by CT scans, toxicities associated with chemotherapy regimens, biomarkers for colon cancer stages, and the role of KRAS mutations. Pre-therapeutic screening for dihydropyrimidine dehydrogenase deficiency is also important in preventing severe toxicity from 5-fluorouracil treatment.